The results demonstrate that APOBEC3A is the major driver of clustered and non-clustered APOBEC3 mutational signatures in cancer cell lines in which results from surrogate assays of APOBEC3 activities recapitulated current debates in the field. The gene discussed is APOBEC3A; the disease is cancer.